Literature DB >> 21150873

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

Andrew S Levey1, Paul E de Jong, Josef Coresh, Meguid El Nahas, Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Bertram L Kasiske, Kai-Uwe Eckardt.   

Abstract

The definition and classification for chronic kidney disease was proposed by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) in 2002 and endorsed by the Kidney Disease: Improving Global Outcomes (KDIGO) in 2004. This framework promoted increased attention to chronic kidney disease in clinical practice, research and public health, but has also generated debate. It was the position of KDIGO and KDOQI that the definition and classification should reflect patient prognosis and that an analysis of outcomes would answer key questions underlying the debate. KDIGO initiated a collaborative meta-analysis and sponsored a Controversies Conference in October 2009 to examine the relationship of estimated glomerular filtration rate (GFR) and albuminuria to mortality and kidney outcomes. On the basis of analyses in 45 cohorts that included 1,555,332 participants from general, high-risk, and kidney disease populations, conference attendees agreed to retain the current definition for chronic kidney disease of a GFR <60 ml/min per 1.73 m(2) or a urinary albumin-to-creatinine ratio >30 mg/g, and to modify the classification by adding albuminuria stage, subdivision of stage 3, and emphasizing clinical diagnosis. Prognosis could then be assigned based on the clinical diagnosis, stage, and other key factors relevant to specific outcomes. KDIGO has now convened a workgroup to develop a global clinical practice guideline for the definition, classification, and prognosis of chronic kidney disease.

Entities:  

Mesh:

Year:  2010        PMID: 21150873     DOI: 10.1038/ki.2010.483

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  700 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

2.  Age, eGFR, and CKD complications.

Authors:  Jean L Holley
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

Review 3.  Nondialysis chronic kidney disease in 2011: Progression, prediction, populations and possibilities.

Authors:  Adeera Levin
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

4.  Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors:  Hitoshi Yokoyama; Takashi Taguchi; Hitoshi Sugiyama; Hiroshi Sato
Journal:  Clin Exp Nephrol       Date:  2012-02-23       Impact factor: 2.801

5.  Estimated GFR, albuminuria, and complications of chronic kidney disease.

Authors:  Lesley A Inker; Josef Coresh; Andrew S Levey; Marcello Tonelli; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

6.  A proposal for improving the KDIGO renal disease risk table.

Authors:  N R Robles; J F Macias; J Alvarez-Gregori
Journal:  Int Urol Nephrol       Date:  2012-06-27       Impact factor: 2.370

7.  Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.

Authors:  Juan Jesus Carrero; Marco Trevisan; Manish M Sood; Peter Bárány; Hong Xu; Marie Evans; Leif Friberg; Karolina Szummer
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-20       Impact factor: 8.237

8.  Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.

Authors:  Lloyd Mulenga; Patrick Musonda; Albert Mwango; Michael J Vinikoor; Mary-Ann Davies; Aggrey Mweemba; Alexandra Calmy; Jeffrey S Stringer; Olivia Keiser; Benjamin H Chi; Gilles Wandeler
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

9.  Orthostatic changes in systolic blood pressure among SPRINT participants at baseline.

Authors:  Raymond R Townsend; Tara I Chang; Debbie L Cohen; William C Cushman; Gregory W Evans; Stephen P Glasser; William E Haley; Christine Olney; Suzanne Oparil; Rita Del Pinto; Roberto Pisoni; Addison A Taylor; Kausik Umanath; Jackson T Wright; Joseph Yeboah
Journal:  J Am Soc Hypertens       Date:  2016-08-26

10.  Effect of food insecurity on chronic kidney disease in lower-income Americans.

Authors:  Deidra C Crews; Marie Fanelli Kuczmarski; Vanessa Grubbs; Elizabeth Hedgeman; Vahakn B Shahinian; Michele K Evans; Alan B Zonderman; Nilka Rios Burrows; Desmond E Williams; Rajiv Saran; Neil R Powe
Journal:  Am J Nephrol       Date:  2014-01-08       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.